BPIQ Blog

$XBI $152.30 (-1.35%) 📉 COVID: $BNTX (-0.30%) & $PFE (-2.87%) - In Vitro Studies Demonstrate Pfizer and BioNTech COVID-19 Vaccine...

$XBI $154.38 (-1.76%) 📉 COVID: $MRNA (+3.30%) - Moderna Provides U.S. COVID-19 Vaccine Supply Update PIPELINE: $AMRN (-1.06%) - AMARIN...

$XBI $157.14 (+3.00%) 📈 COVID: $MRNA (+12.20%) - Moderna COVID-19 Vaccine Retains Neutralizing Activity Against Emerging Variants First...

$XBI $152.56 (+1.18%) 📈 COVID: $AMPE (+16.13%) - AMPIO PHARMACEUTICALS ONGOING PHASE I CLINICAL TRIAL FOR INHALATION TREATMENT OF...

$XBI $150.78 (-2.17%) 📉 COVID: $VBIV (-6.53%) - VBI Vaccines Announces Progress of Coronavirus Vaccine Program...

$XBI $154.13 (-0.09%) 📉 COVID: $PFE (-0.65%) & $BNTX (-1.40%) - Pfizer and BioNTech Publish Results of Study Showing COVID-19 Vaccine...

$XBI $154.22 (+1.64%) 📈 COVID: $GRTS (+248.51%) - Gritstone Advances Second Generation COVID-19 Vaccine “CORAL” Program with Support...

$XBI $151.73 (-1.11%) 📉 PIPELINE: $AVEO (-0.37%) - AVEO Oncology Announces Results from Phase 1b Portion of DEDUCTIVE Study of Tivozanib...

$XBI $153.43 (+3.27%) 📈 COVID: $VRNA (+4.64%) - Verona Pharma Completes Enrollment in Pilot Study of pMDI Ensifentrine in U.S. Patients...

$XBI $148.57 (-0.52%) 📉 PIPELINE: $ARQT (-0.66%) - Arcutis Initiates Pivotal Phase 3 Clinical Trials Evaluating Topical Roflumilast...

$XBI $149.35 (+0.87%) 📈 COVID: $MRNA (+6.22%) - Swissmedic Authorizes COVID-19 Vaccine Moderna for Use in Switzerland...

$XBI $148.06 (-0.99%) 📉 COVID: $HGEN (+7.61%) - Humanigen and EVERSANA Announce Partnership to Support the Launch and Commercialization...

$XBI $149.54 (+0.22%) 📈 COVID: $BNTX (+7.15%) - An In Vitro Study Shows Pfizer-BioNTech COVID-19 Vaccine Elicits Antibodies that...

$XBI $149.21 (+4.11%) 📈 COVID: $NVAX (+3.56%) - Novavax Finalizes Agreement with Commonwealth of Australia for 51 Million Doses of...

$XBI $143.32 (+2.04%) 📈 PIPELINE: $IMRA (-37.97%) - Imara Reports Phase 2a Clinical Trial Results of IMR-687 in Adult Patients with...

$XBI -0.35% 📉 COVID: $CERC (+10.61%) - Cerecor Announces Successful Proof of Concept Data for CERC-002, a Unique LIGHT-Neutralizing...

$XBI $140.95 (+0.12%) 📈 COVID: $ARCT (+12.72%) - Arcturus Therapeutics Receives FDA Allowance to Proceed with Phase 2 Study of ARCT-021...

$XBI $140.78 (-2.29%) 📉 COVID: $RDHL (-5.61%) - RedHill Biopharma Announces Positive Top-Line Safety and Efficacy Data from Phase 2...

$XBI $144.08 (+1.34) 📈 COVID: $MRNA (-2.85%) - Supply agreement for ex-US https://investors.modernatx.com/news-releases/news-release-det...

XBI $142.17 (-2.93%) 📉 COVID: $MRNA (+2.68%) - Presenting at Goldman Sachs conference. https://investors.modernatx.com/news-releases/new...